BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Kaur G, Poljak A, Ali SA, Zhong L, Raftery MJ, Sachdev P. Extending the Depth of Human Plasma Proteome Coverage Using Simple Fractionation Techniques. J Proteome Res 2021;20:1261-79. [PMID: 33471535 DOI: 10.1021/acs.jproteome.0c00670] [Cited by in Crossref: 4] [Cited by in F6Publishing: 10] [Article Influence: 4.0] [Reference Citation Analysis]
Number Citing Articles
1 Rice SJ, Belani CP. Optimizing data-independent acquisition (DIA) spectral library workflows for plasma proteomics studies. Proteomics 2022;:e2200125. [PMID: 35708973 DOI: 10.1002/pmic.202200125] [Reference Citation Analysis]
2 Ghorbanpoor H, Dizaji AN, Akcakoca I, Blair EO, Ozturk Y, Hoskisson P, Kocagoz T, Avci H, Corrigan DK, Guzel FD. A fully integrated rapid on-chip antibiotic susceptibility test – A case study for Mycobacterium smegmatis. Sensors and Actuators A: Physical 2022;339:113515. [DOI: 10.1016/j.sna.2022.113515] [Reference Citation Analysis]
3 Neset L, Takayidza G, Berven FS, Hernandez-Valladares M. Comparing Efficiency of Lysis Buffer Solutions and Sample Preparation Methods for Liquid Chromatography-Mass Spectrometry Analysis of Human Cells and Plasma. Molecules 2022;27:3390. [PMID: 35684327 DOI: 10.3390/molecules27113390] [Reference Citation Analysis]
4 Tognetti M, Sklodowski K, Müller S, Kamber D, Muntel J, Bruderer R, Reiter L. Biomarker Candidates for Tumors Identified from Deep-Profiled Plasma Stem Predominantly from the Low Abundant Area. J Proteome Res 2022. [PMID: 35605973 DOI: 10.1021/acs.jproteome.2c00122] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
5 Palstrøm NB, Matthiesen R, Rasmussen LM, Beck HC. Recent Developments in Clinical Plasma Proteomics—Applied to Cardiovascular Research. Biomedicines 2022;10:162. [DOI: 10.3390/biomedicines10010162] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
6 Andersen LC, Palstrøm NB, Diederichsen A, Lindholt JS, Rasmussen LM, Beck HC. Determining Plasma Protein Variation Parameters as a Prerequisite for Biomarker Studies-A TMT-Based LC-MSMS Proteome Investigation. Proteomes 2021;9:47. [PMID: 34941812 DOI: 10.3390/proteomes9040047] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
7 Lill JR, Mathews WR, Rose CM, Schirle M. Proteomics in the pharmaceutical and biotechnology industry: a look to the next decade. Expert Rev Proteomics 2021;:1-24. [PMID: 34320887 DOI: 10.1080/14789450.2021.1962300] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
8 Cao X, Sandberg A, Araújo JE, Cvetkovski F, Berglund E, Eriksson LE, Pernemalm M. Evaluation of Spin Columns for Human Plasma Depletion to Facilitate MS-Based Proteomics Analysis of Plasma. J Proteome Res 2021. [PMID: 34320313 DOI: 10.1021/acs.jproteome.1c00378] [Cited by in F6Publishing: 4] [Reference Citation Analysis]
9 Su M, Zhang Z, Zhou L, Han C, Huang C, Nice EC. Proteomics, Personalized Medicine and Cancer. Cancers (Basel) 2021;13:2512. [PMID: 34063807 DOI: 10.3390/cancers13112512] [Cited by in Crossref: 2] [Cited by in F6Publishing: 8] [Article Influence: 2.0] [Reference Citation Analysis]
10 Solanki SS, Singh P, Kashyap P, Sansi MS, Ali SA. Promising role of defensins peptides as therapeutics to combat against viral infection. Microb Pathog 2021;155:104930. [PMID: 33933603 DOI: 10.1016/j.micpath.2021.104930] [Cited by in Crossref: 2] [Cited by in F6Publishing: 18] [Article Influence: 2.0] [Reference Citation Analysis]